Chapter 9: Sympathomimetics Flashcards

1
Q

A drug that decreases appetite

A

Anorexiant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A synthetic sympathomimetic with isopropylamine in its structure (eg, amphetamine, ephedrine). Unlike catecholamines, these usually have oral activity, a long half-life, CNS activity, and cause release of stored catecholamines

A

Phenylisopropylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type of adrenoceptors outside the CNS found in adipocytes, which stimulates lipolysis

A

Beta 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type of adrenoceptors outside the CNS found in adipocytes, which inhibits lipolysis

A

Alpha 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type of adrenoceptors outside the CNS found in most vascular smooth muscle responsible for contraction

A

Alpha 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type of adrenoceptors in the heart (stimulates rate and force) and the juxtaglomerular cells of kidney (stimulates renin release)

A

Beta 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the drug of choice for the immediate treatment of anaphylactic shock (hypotension, bronchospasm, angioedema) because it is an effective physiologic antagonist of many of the mediators of anaphylaxis?

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Noncatecholamine alpha-selective sympathomimetic used as decongestant, mydriatic, neurogenic hypotension

A

Phenylephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Noncatecholamines beta 2-selective agonist used for acute bronchospasm

A

Albuterol, metaproterenol, terbutaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary transmitter at the sympathetic postganglionic neuron-effector cell synapses in most tissues? (except: eccrine sweat glands and vasodilator sympathetic fibers in skeletal muscle)

A

Norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inhibits synthesis of dopamine by inhibiting hydroxylation of tyrosine to DOPA (enzyme: tyrosine hydroxylase)

A

Metyrosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blocks the transfer of DOPA into vesicles

A

Reserpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhibits entry of calcium triggers interaction among SNARE proteins (VAMPs and SNAPs)

A

Guanethidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Promotes entry of calcium triggers interaction among SNARE proteins (VAMPs and SNAPs)

A

Amphetamines and Tyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inhibits diffusion and reuptake of Dopa via NET and DAT in synaptic cleft

A

Cocaine and TCAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adrenoceptor that stimulates platelet aggregation

A

Alpha 2 adrenergic agonist

17
Q

Sympathomimetic (non-selective, direct-acting)
b1 = b2 > a
Used for severe Asthma, COPD, hemostasis

A

Epinephrine

18
Q

Sympathomimetic (non-selective, direct-acting)
a > b1&raquo_space; b2 (almost negligible)
First line treatment for refractory hypotension in severe sepsis

A

Norepinephrine

19
Q

Dose-dependent actions of dopamine:

A

LOW DOSE (0.5 to 3 mcg/kg/min)

  • D1 and D2 receptors
  • Vasodilation, decreased arterial BP and increased renal and splanchnic blood flow

MEDIUM DOSE (3-10 mcg/kg/min)

  • β1 receptors
  • Increased CO (chronotropy and contractility)

HIGH DOSE (>10 mcg/kg/min)

  • α1 receptors
  • Leads to arterial and venous vasoconstriction, increased SVR, increased BP and increased CO
20
Q

A non-selective beta adrenergic receptor agonist

used in asthma and for sustained increases in HR (during pacemaker insertion for bradydysrhythmia)

A

Isoproterenol

albuterol or salbutamol is beta-2 selective

21
Q

Drug of choice for Alpha-1 agonist overdose

A

Phentolamine

22
Q

Pseudoephedrine is avoided in the 1st trimester because it may be associated with possible risk of:

A

Gastroschisis

23
Q

A unilateral condition that results from interruption of sympathetic nerves to the face. Symptoms include vasodilation, ptosis, miosis and loss of sweating on the affected side.

A

Horner’s syndrome

24
Q

Activates a2 adrenergic receptors by decreasing central sympathetic outflow (lowering peripheral vascular resistance), used in preeclampsia and gestational HPN

A

Methyldopa

25
Q

Sympathomimetic of choice for:
Acute heart failure, septic shock

Goal:
Increased cardiac output

A

Beta 1 and D1 agonists

26
Q

Sympathomimetic of choice for:
Hemostasis, decongestion, and spinal shock

Goal:
Vasoconstriction and temporary maintenance of BP

A

Alpha 1 agonist

27
Q

Sympathomimetic of choice for:
Bronchospasm, premature labor

Goal:
Bronchodilation, uterine SmM relaxation

A

Beta 2 agonist

28
Q

Sympathomimetic of choice for:
Hypertension, glaucoma

Goal:
Decrease BP

A

Alpha 2 agonist